These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 31655378)

  • 21. Lack of evidence for predictive utility from resting state fMRI data for individual exposure-based cognitive behavioral therapy outcomes: A machine learning study in two large multi-site samples in anxiety disorders.
    Hilbert K; Böhnlein J; Meinke C; Chavanne AV; Langhammer T; Stumpe L; Winter N; Leenings R; Adolph D; Arolt V; Bischoff S; Cwik JC; Deckert J; Domschke K; Fydrich T; Gathmann B; Hamm AO; Heinig I; Herrmann MJ; Hollandt M; Hoyer J; Junghöfer M; Kircher T; Koelkebeck K; Lotze M; Margraf J; Mumm JLM; Neudeck P; Pauli P; Pittig A; Plag J; Richter J; Ridderbusch IC; Rief W; Schneider S; Schwarzmeier H; Seeger FR; Siminski N; Straube B; Straube T; Ströhle A; Wittchen HU; Wroblewski A; Yang Y; Roesmann K; Leehr EJ; Dannlowski U; Lueken U
    Neuroimage; 2024 Jul; 295():120639. PubMed ID: 38796977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleus accumbens volume as a predictor of anxiety symptom improvement following CBT and SSRI treatment in two independent samples.
    Burkhouse KL; Jagan Jimmy ; Defelice N; Klumpp H; Ajilore O; Hosseini B; Fitzgerald KD; Monk CS; Phan KL
    Neuropsychopharmacology; 2020 Feb; 45(3):561-569. PubMed ID: 31756730
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered neural correlates of affective processing after internet-delivered cognitive behavior therapy for social anxiety disorder.
    Månsson KN; Carlbring P; Frick A; Engman J; Olsson CJ; Bodlund O; Furmark T; Andersson G
    Psychiatry Res; 2013 Dec; 214(3):229-37. PubMed ID: 24064198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anterior cingulate cortex activity as a candidate biomarker for treatment selection in social anxiety disorder.
    Frick A; Engman J; Wahlstedt K; Gingnell M; Fredrikson M; Furmark T
    BJPsych Open; 2018; 4(3):157-159. PubMed ID: 29922481
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment for social anxiety disorder alters functional connectivity in emotion regulation neural circuitry.
    Young KS; Burklund LJ; Torre JB; Saxbe D; Lieberman MD; Craske MG
    Psychiatry Res Neuroimaging; 2017 Mar; 261():44-51. PubMed ID: 28129555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy.
    Hjorth O; Frick A; Gingnell M; Engman J; Björkstrand J; Faria V; Alaie I; Carlbring P; Andersson G; Jonasson M; Lubberink M; Antoni G; Reis M; Wahlstedt K; Fredrikson M; Furmark T
    Transl Psychiatry; 2022 Oct; 12(1):436. PubMed ID: 36202797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structural but not functional neuroplasticity one year after effective cognitive behaviour therapy for social anxiety disorder.
    Månsson KNT; Salami A; Carlbring P; Boraxbekk CJ; Andersson G; Furmark T
    Behav Brain Res; 2017 Feb; 318():45-51. PubMed ID: 27838341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anxious Children and Adolescents Non-responding to CBT: Clinical Predictors and Families' Experiences of Therapy.
    Lundkvist-Houndoumadi I; Thastum M
    Clin Psychol Psychother; 2017 Jan; 24(1):82-93. PubMed ID: 26514088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combining selective serotonin reuptake inhibitors and cognitive behavioral therapy in youth with depression and anxiety.
    Strawn JR; Mills JA; Suresh V; Peris TS; Walkup JT; Croarkin PE
    J Affect Disord; 2022 Feb; 298(Pt A):292-300. PubMed ID: 34728290
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expectancy effects on serotonin and dopamine transporters during SSRI treatment of social anxiety disorder: a randomized clinical trial.
    Hjorth OR; Frick A; Gingnell M; Hoppe JM; Faria V; Hultberg S; Alaie I; Månsson KNT; Rosén J; Reis M; Wahlstedt K; Jonasson M; Lubberink M; Antoni G; Fredrikson M; Furmark T
    Transl Psychiatry; 2021 Nov; 11(1):559. PubMed ID: 34732695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neural connectivity during affect labeling predicts treatment response to psychological therapies for social anxiety disorder.
    Young KS; LeBeau RT; Niles AN; Hsu KJ; Burklund LJ; Mesri B; Saxbe D; Lieberman MD; Craske MG
    J Affect Disord; 2019 Jan; 242():105-110. PubMed ID: 30173058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive-behavioral therapy augmentation of SSRI reduces cortisol levels in older adults with generalized anxiety disorder: A randomized clinical trial.
    Rosnick CB; Wetherell JL; White KS; Andreescu C; Dixon D; Lenze EJ
    J Consult Clin Psychol; 2016 Apr; 84(4):345-52. PubMed ID: 26881447
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Common changes in cerebral blood flow in patients with social phobia treated with citalopram or cognitive-behavioral therapy.
    Furmark T; Tillfors M; Marteinsdottir I; Fischer H; Pissiota A; Långström B; Fredrikson M
    Arch Gen Psychiatry; 2002 May; 59(5):425-33. PubMed ID: 11982446
    [TBL] [Abstract][Full Text] [Related]  

  • 36. fMRI response to negative words and SSRI treatment outcome in major depressive disorder: a preliminary study.
    Miller JM; Schneck N; Siegle GJ; Chen Y; Ogden RT; Kikuchi T; Oquendo MA; Mann JJ; Parsey RV
    Psychiatry Res; 2013 Dec; 214(3):296-305. PubMed ID: 24446548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Escitalopram for persistent symptoms of generalized anxiety disorder after CBT: a pilot study.
    Schneier FR; Belzer KD; Kishon R; Amsel L; Simpson HB
    J Nerv Ment Dis; 2010 Jun; 198(6):458-61. PubMed ID: 20531128
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amygdala subregions tied to SSRI and placebo response in patients with social anxiety disorder.
    Faria V; Appel L; Åhs F; Linnman C; Pissiota A; Frans Ö; Bani M; Bettica P; Pich EM; Jacobsson E; Wahlstedt K; Fredrikson M; Furmark T
    Neuropsychopharmacology; 2012 Sep; 37(10):2222-32. PubMed ID: 22617357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A 5-Year follow-up of internet-based cognitive behavior therapy for social anxiety disorder.
    Hedman E; Furmark T; Carlbring P; Ljótsson B; Rück C; Lindefors N; Andersson G
    J Med Internet Res; 2011 Jun; 13(2):e39. PubMed ID: 21676694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered time course of amygdala activation during speech anticipation in social anxiety disorder.
    Davies CD; Young K; Torre JB; Burklund LJ; Goldin PR; Brown LA; Niles AN; Lieberman MD; Craske MG
    J Affect Disord; 2017 Feb; 209():23-29. PubMed ID: 27870942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.